Collagen-endocytosing TAMs derived from CCR2+ inflammatory monocytes recruited to and altered the TME through endocytic collagen turnover, which further centrally engaged in collagen degradation and promote invasive tumor growth [29]. This evidence concerns the gene CCR2 and neoplasm.